Adage Capital Management
Adage Capital is a Boston-based hedge fund founded by Phillip Gross which held nearly $24 billion in securities at the end of the quarter ended September 30, 2010.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
The firm focuses on managing S&P 500 assets predominantly for Endowments and Foundations such as Harvard University, Northwestern University, Dartmouth College, the American Red Cross and the Getty Foundation.
View Older Stories View More Recent Stories
-
Form SC 13G/A VAPOTHERM INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Summit Materials, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Intec Pharma Ltd. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Solaris Oilfield Infrast Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Syndax Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Immunovant, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Spring Bank Pharmaceutic Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A CONTRAFECT Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Regalwood Global Energy Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Aevi Genomic Medicine, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ANAPTYSBIO, INC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ROCKET PHARMACEUTICALS, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Aldeyra Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Karyopharm Therapeutics Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A GMS Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Ferroglobe PLC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Xenon Pharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A National Vision Holdings Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Venator Materials PLC Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Eiger BioPharmaceuticals Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Under Armour, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A PELOTON INTERACTIVE, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A BlueLinx Holdings Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A STEMLINE THERAPEUTICS Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Aeglea BioTherapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ARDELYX, INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ABEONA THERAPEUTICS INC. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ProQR Therapeutics N.V. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A AERIE PHARMACEUTICALS Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A ORBCOMM Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A OLIN Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Zosano Pharma Corp Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A NOVA MEASURING INSTRUMEN Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A EverQuote, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Nine Energy Service, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A LogicBio Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G/A Adverum Biotechnologies, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form D/A Adage Capital Partners,
-
Form SC 13G MARINUS PHARMACEUTICALS Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
ImaginAb Initiates Phase II Clinical Trial at Penn Medicine
-
Form SC 13G Alussa Energy Acquisitio Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Karyopharm Therapeutics Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G Galera Therapeutics, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form 13F-HR ADAGE CAPITAL PARTNERS For: Sep 30
-
ImaginAb signs multi-party collaboration agreement with three global pharmaceutical companies to help further develop company's CD8 ImmunoPET technology
-
ImaginAb To Present At Innovation Showcase 2019 Hosted By The Lundquist Institute
-
ImaginAb Announces Publication of Data on First-In-Human Imaging in Patients with Solid Malignancies in The Journal of Nuclear Medicine
-
Form SC 13G PELOTON INTERACTIVE, Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Form SC 13G KushCo Holdings, Inc. Filed by: ADAGE CAPITAL PARTNERS GP, L.L.C.
-
Immunovant to Merge with Health Sciences Acquisitions Corporation, Creating New Publicly Listed FcRn-Focused Company

